Application of photodynamic therapy in the sterilisation of tumour cells transplanted into laboratory animals

• Autorzy: Jurczyszyn K , Ziolkowski P. , Klytta M. , Piasecki T.
• Języki publikacji: EN

Abstrakty

EN

In this study, we tried to estimate the effectiveness of the antimicrobial activity of photodynamic therapy (PDT) without the destruction of tumour cells. Chlorin e6 in concentrations from 0.05 to 1.0 µg/mL and total dose of light 100 J/sq.cm were used. Samples from different tumours were tested for a presence of bacteria. Next, cells from the same tumours were treated with chlorin e6-PDT, chlorin e6, and light alone, or not treated. The survival rate was counted, and the cells were injected back into the animals. PDT caused the eradication of bacteria such as Proteus sp., Streptococcus α-haemolyticus, and others: the specimen became aseptic. After Ce6-PDT treatment and in control groups, tumour growth was observed in all rats 7-10 d after transplantation. The tumours were palpable and macroscopically visible. Our studies showed that PDT kills bacterial flora without the destruction of tumour cells. Thus, tumour cells free of bacteria could be used for other experiments.

Słowa kluczowe

EN

photodynamic therapy; bacteria; sterilization; chlorin e6; tumour cell; laboratory animal

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2009
• Tom: 53
• Numer: 1
• Opis fizyczny: p.123-128,fig.,ref.

Twórcy

autor

Jurczyszyn K

• Wroclaw Medical University, 50-368 Wroclaw, Poland

autor

Ziolkowski P.

autor

Klytta M.

autor

Piasecki T.

Bibliografia

• 1. Banfi S., Caruso E., Buccafurni L., Battini V., Zazzaron S., Barbieri P., Orlandi V.: Antibacterial activity of tetraaryl-porphyrin photosensitizers: an in vitro study on Gram-negative and Gram-positive bacteria. J Photochem Photobiol B 2006, 85, 28-38.
• 2. Bombelli C., Bordi F., Ferro S., Giansanti L., Jori G., Mancini G., Mazzuca C., Monti D., Ricchelli F., Sennato S., Venanzi M.: New cationic liposomes as vehicles of m-tetrahydroxyphenylchlorin in photodynamic therapy of infectious diseases. Mol Pharm 2008, 5, 672-679.
• 3. Embleton M.L., Nair S.P., Cookson B.D., Wilson M.: Selective lethal photosensitization of methicillin-resistant Staphylococcus aureus using an IgG-tin(IV) chlorin e6 conjugate. J Antimicrob Chemother 2002, 50, 857-864.
• 4. Embleton M.L., Nair S.P., Heywood W., Menon D.C., Cookson B.D., Wilson M.: Development of a novel targeting system for lethal photosensitization of antibiotic-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother 2005, 49, 3690-3696.
• 5. Ferro S., Ricchelli F., Monti D., Mancini G., Jori G.: Efficient photoinactivation of methicillin-resistant Staphylococcus aureus by a novel porphyrin incorporated into a poly-cationic liposome. Int J Biochem Cell Biol 2007, 39, 1026-1034.
• 6. Fimple J.L., Fontana C.R., Foschi F., Ruggiero K., Song X., Pagonis T.C., Tanner A.C., Kent R., Doukas A.G., Stashenko P.P., Soukos N.S.: Photodynamic treatment of endodontic polymicrobial infection in vitro. J Endod 2008, 34, 728-734.
• 7. Fuchs B.B., Tegos G.P., Hamblin M.R., Mylonakis E.: Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob Agents Chemother 2007, 51, 2929- 2936.
• 8. Gad F., Zahra T., Hasan T., Hamblin M.R.: Effects of growth phase and extracellular slime on photodynamic inactivation of Gram-positive pathogenic bacteria. Antimicrob Agents Chemother 2004, 48, 2173-2178.
• 9. Hamblin M.R., O'Donnell D.A., Murthy N., Contag C.H., Hasan T.: Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol 2002, 75, 51-57.
• 10. Lambrechts S.A., Demidova T.N., Aalders M.C., Hasan T., Hamblin M.R.: Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci 2005, 4, 503-509.
• 11. Maisch T., Szeimies R.M., Jori G., Abels C.: Antibacterial photodynamic therapy in dermatology. Photochem Photobiol Sci 2004, 3, 907-917.
• 12. Mohr H., Redecker-Klein A.: Inactivation of pathogens in platelet concentrates by using a two-step procedure. Vox Sang 2003, 84, 96-104.
• 13. Mróz P., Tegos G.P., Gali H., Wharton T., Sarna T., Hamblin M.R.: Photodynamic therapy with fullerenes. Photochem Photobiol Sci 2007, 6, 1139-1149.
• 14. Phoenix D.A., Harris F.: Light activated compounds as antimicrobial agents - patently obvious ? Recent Patents Anti-Infect Drug Disc 2006, 1, 181-199.
• 15. Trannoy L.L., Terpstra F.G., de Korte D., Lagerberg J.W., Verhoeven A.J., Brand A., van Engelenburg F.A.: Differential sensitivities of pathogens in red cell concentrates to Tri-P-(4)-photoinactivation. Vox Sang 2006, 91, 111-118.
• 16. Zeina B., Greenman J., Purcell W.M., Das B.: Killing of cutaneous microbial species by photodynamic therapy. Br J Dermatol 2001, 144, 274-278.
• 17. Ziółkowski P., Piasecki E., Jeleń M., Marszalik P., Berezin D.B., El Merouani A., Gomez A.M., Perez V., Bonnett R., Shatunov P.A., Pinto R.M., Caballero S., De Madariaga M.A., Mora M., Sagrista M.L., Postigo F., Koifman O.I., Semeykin A.S.: PDT photosensitisers for blood sterilization: viruses photoinactivation and red blood cells toxicity assays. In: Advances in Porphyrin Chemistry, edited by Golubchikov O.A., St.Petersburg University, 2001, vol. 3, chapter X, pp. 179-190.
• 18. Ziółkowski P., Bonnett R., Valles M.A., Piasecki E., Jeleń M., Bronowicz A., Ziółkowska J., Symonowicz K.: Photodynamic therapy of virus-contaminated red blood cell concentrates. Acta Bio-optica Inform Med 2005, 12, 75-77.